Aurora, CO, United States of America

Maria L Amaya

This inventor holds 1 USPTO granted patent. Top assignee: University of Colorado. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria L Amaya. Retrieved from https://idiyas.com/inventor/maria-l-amaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria L Amaya: Innovator in Cancer Treatment

Introduction

Maria L Amaya is a prominent inventor based in Aurora, CO (US). She has made significant contributions to the field of cancer research through her innovative work on STAT3 transcription factor inhibitors. Her research focuses on developing compounds that can inhibit the activity of Signal transducer and activator of transcription 3 (STAT3), which is crucial in the treatment of cancer and other diseases.

Latest Patents

Maria L Amaya holds 1 patent for her invention titled "STAT3 transcription factor inhibitors and methods of using the same." This patent encompasses compounds that inhibit STAT3 activity, along with methods for utilizing these compounds in therapeutic applications.

Career Highlights

Maria is affiliated with the University of Colorado, where she continues her research and development efforts. Her work has the potential to lead to groundbreaking treatments for various diseases, particularly cancer.

Collaborations

Maria collaborates with esteemed colleagues, including Philip Reigan and Donald S Backos, to advance her research and explore new avenues in cancer treatment.

Conclusion

Maria L Amaya is a dedicated inventor whose work in developing STAT3 inhibitors showcases her commitment to improving cancer therapies. Her contributions to the field are invaluable and highlight the importance of innovation in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…